NCT05182177 - The SurgiMend PRS Retrospective Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Reconstructive Surgical Procedures

Interventions

DEVICE

SurgiMend PRS

SurgiMend® PRS and SurgiMend® PRS Meshed are intended for implantation to reinforce soft tissue where weakness exists and for surgical repair of damaged or ruptured soft tissue membranes. SurgiMend® PRS and SurgiMend® PRS Meshed are specifically indicated for plastic and reconstructive surgery, including breast reconstruction.

Trial Locations (6)

37122

AULSS9 Scaligera, Verona

Unknown

Ospedale Regionale di Lugano; Sede Ospedale Italiano, Viganello

North Manchester General Hospital, Manchester

NW3 2GQ

Royal Free Hospital, London

S10 2JF

Royal Hallamshire Hospital, Sheffield

SE1 9RT

Guy's and St Thomas' NHS Foundation Trust, London